Literature DB >> 18157609

[Austrian Guidelines for Prophylaxis of Venous Thromboembolism].

Ingrid Pabinger1, Sabine Eichinger, Erich Minar, Herwig Niessner.   

Abstract

Venous thromboembolism occurs in a significant number of patients in typical risk situations (e.g. surgery or trauma). However, in these special high-risk situations anticoagulants, particularly low molecular weight heparin, allow for a decrease in the number of venous thromboses, pulmonary embolisms and deaths caused by pulmonary embolism. Only the wide-spread and adequate use of antithrombotics can safeguard against venous thromboembolism in these various risk situations. Guidelines constitute an integrative part of quality management and ensure the application of evidence-based medicine. The present consensus on thrombosis prophylaxis in Austria has been elaborated by 23 experts in the fields of hemostasis research, angiology, surgery, orthopedics, internal medicine, anaesthesiology and pharmacology. The recommendations for the management of thrombosis prophylaxis in the fields of general surgery, orthopaedic and trauma surgery and internal medicine have been elaborated drawing on the Guidelines issued by the American College of Chest Physicians. Included are recommendations on indications as well as the choice of antithrombotics, dose and duration of therapy for the various conditions. The Austrian Guidelines for Venous Thromboembolism Prophylaxis are meant to be a basis for standardising procedures in the above-mentioned fields, thus contributing to an improved management of risk situations by physicians and health care staff and providing more safety for patients.

Entities:  

Mesh:

Year:  2007        PMID: 18157609     DOI: 10.1007/s00508-007-0915-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  11 in total

1.  Incidence of venous thromboembolism verified by necropsy over 30 years.

Authors:  B Lindblad; N H Sternby; D Bergqvist
Journal:  BMJ       Date:  1991-03-23

Review 2.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

Authors:  Gordon Guyatt; David Gutterman; Michael H Baumann; Doreen Addrizzo-Harris; Elaine M Hylek; Barbara Phillips; Gary Raskob; Sandra Zelman Lewis; Holger Schünemann
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

3.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

4.  Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.

Authors:  Clifford W Colwell; Lewis M Kwong; Alexander G G Turpie; Bruce L Davidson
Journal:  J Arthroplasty       Date:  2006-01       Impact factor: 4.757

5.  Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

Authors:  Bengt I Eriksson; Michael R Lassen
Journal:  Arch Intern Med       Date:  2003-06-09

Review 6.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Chronic leg ulcers: an underestimated problem in primary health care among elderly patients.

Authors:  O Nelzén; D Bergqvist; A Lindhagen; T Hallböök
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

8.  Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

9.  A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Authors:  M Nordström; B Lindblad; D Bergqvist; T Kjellström
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

10.  Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

Authors:  Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Journal:  Arch Intern Med       Date:  2002-09-09
View more
  7 in total

1.  [Guidelines for prevention of venous thromboembolism in Austria].

Authors:  Heinrich Thaler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey.

Authors:  Petra Jancar; Tina Morgan; Ales Mrhar; Mitja Kosnik; Mitja Lainscak
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Robot-assisted laparoscopic cardiomyotomy.

Authors:  Heinz F Wykypiel; Johannes Bodner; Florian Augustin; Oliver Renz; Elisabeth Hoeller; Thomas Schmid
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  New anticoagulants: perioperative considerations.

Authors:  Sibylle A Kozek-Langenecker
Journal:  Wien Med Wochenschr       Date:  2011-02

Review 5.  [Perioperative thromboprophylaxis in adults].

Authors:  Sabine Eichinger
Journal:  Wien Med Wochenschr       Date:  2009-10

6.  A prospective cohort study on the effectiveness of 3500 IU versus 5000 IU bemiparin in the prophylaxis of postoperative thrombotic events in obese patients undergoing orthopedic surgery.

Authors:  Patrick Vavken; Andreas Lunzer; Josef Georg Grohs
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

7.  [Prevention of venous thromboembolism in musculoskeletal surgery].

Authors:  Ingrid Pabinger-Fasching; Sabine Eichinger-Hasenauer; Josef Grohs; Josef Hochreiter; Norbert Kastner; Hans Christian Korninger; Sibylle Kozek-Langenecker; Stefan Marlovits; Herwig Niessner; Franz Rachbauer; Peter Ritschl; Christian Wurnig; Reinhard Windhager
Journal:  Wien Klin Wochenschr       Date:  2014-05-14       Impact factor: 1.704

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.